204.07 USD
▼-12.51-5.78%
盘后 204.20 +0.06%
2026-09-15
市值
$10.69B
市盈率
—
EPS
-3.76
股息率
—
52 周区间
112.90 – 260.19
成交量
591.32K
Beta
0.71
目标价
285.42
52W 低 112.9052W 高 260.19
价格走势
公司简介
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 ago...